Rearchers at Oxford, in collaboration with Columbia University and Barts Cancer Institute at Queen Mary University of London have found that the signature of metal ions present in urine samples is an accurate indicator of pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of cancer.
The discovery could signal the possibility of a new and completely non-invasive test for pancreatic cancer. The study has been published in Metallomics. Read more . . .